With a high sensitivity for detecting disease recurrence, follow-up imaging using PET/CT may help to more successfully guide the management of patients with non-Hodgkin lymphoma (NHL) who are at risk for disease recurrence, according to the results of a study presented during the 2015 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (abstract 599). {read more here}